Cargando…
The Traditional Chinese Medicine Formula FTZ Protects against Cardiac Fibrosis by Suppressing the TGFβ1-Smad2/3 Pathway
BACKGROUND: Fu fang Zhen Zhu Tiao Zhi (FTZ) is a patented preparation of Chinese herbal medicine that has been used as a natural medicine to treat several chronic diseases including cardiovascular disease. However, its effects on cardiac fibrosis remain unclear. Therefore, this study was designed to...
Autores principales: | Zhang, Yue, Wang, Dongwei, Wu, Kaili, Shao, Xiaoqi, Diao, Hongtao, Wang, Zhiying, Sun, Mengxian, Huang, Xueying, Li, Yun, Tang, Xinyuan, Yan, Meiling, Guo, Jiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9042631/ https://www.ncbi.nlm.nih.gov/pubmed/35497919 http://dx.doi.org/10.1155/2022/5642307 |
Ejemplares similares
-
Fu Fang Zhen Zhu Tiao Zhi Capsules Protect against Myocardial Ischemia by Inhibiting Cardiomyocyte Pyroptosis
por: Shao, Xiaoqi, et al.
Publicado: (2022) -
Activation of Ftz-F1-Responsive Genes through Ftz/Ftz-F1 Dependent Enhancers
por: Field, Amanda, et al.
Publicado: (2016) -
FTZ Ameliorates Diabetic Cardiomyopathy by Inhibiting Inflammation and Cardiac Fibrosis in the Streptozotocin-Induced Model
por: Wang, Lexun, et al.
Publicado: (2021) -
BAG3 Alleviates Atherosclerosis by Inhibiting Endothelial-to-Mesenchymal Transition via Autophagy Activation
por: Diao, Hongtao, et al.
Publicado: (2022) -
Astragaloside Inhibits Hepatic Fibrosis by Modulation of TGF-β1/Smad Signaling Pathway
por: Yuan, Xingxing, et al.
Publicado: (2018)